Rewind Therapeutics Appoints Irene Knuesel, PhD, as Chief Scientific Officer
- Former Roche Head of Neuroimmunology strengthens Rewind´s neuroimmunology and neurodegeneration expertise Leuven, Belgium, October 19, 2022 --- Rewind Therapeutics, a company…